Skip to main content (Press Enter).
Skip auxiliary navigation (Press Enter).
Terms and Conditions
Where HIV Care Providers Connect
Skip main navigation (Press Enter).
Rules, Etiquette, and Privacy Guidelines
E-mail Whitelist Information
About the Academy Mentoring Program
Back to discussions
Posted 08-18-2023 08:20
I have a newly diagnosed 28yo male with initial CD4 of 418 and viral load of 780 who I started on Biktarvy, but he's strongly pushing for eventual Cabenuva switch based on all those adds he's seeing. His genotype showed no integrase resistance, a single NRTI mutation (Q151L), no PI resistance, but multiple NNRTI mutations (I178L, V189I, P225H, V245E, L283I, P225H) with the interpretation "Doravirine, Efavirenz: resistance possible, Etravirine, Rilpivirine sensitive."
Cabenuva with the rilpivirine SHOULD be fine, but given the (admittedly) small percentage of patients failing Cabenuva with INI and/or NNRTI resistance would everybody feel more confident than I'm feeling about this switch? Biktarvy seems to be a perfect choice in this patient.
New Best Answer
This thread already has a best answer. Would you like to mark this message as the new best answer?
Copyright 2020. All rights reserved.
Powered by Higher Logic